Upstream Bio, Inc. (UPB) Earnings
Upstream Bio, Inc. is expected to report next earnings on November 4, 2026 (in NaN days), with a consensus EPS estimate of $-0.73. UPB has beaten EPS estimates in 2 of its last 6 reported quarters (average surprise +4.1% over the last four).
Next earnings
Nov 4, 2026in NaN days
EPS est $-0.73 · Revenue est $522500
Track record
Beat EPS in 2 of 6 quarters
Avg surprise +4.1% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 11, 2026 | $-0.78 | $-0.73 | +6.4% | $773000 | +37.7% |
| May 13, 2026 | $-0.74 | $-0.75 | -1.2% | $1M | +0.6% |
| Mar 26, 2026 | $-0.73 | $-0.79 | -8.2% | $668000 | +14.4% |
| Nov 5, 2025 | $-0.78 | $-0.63 | +19.2% | $683000 | +31.0% |
| Mar 13, 2025 | $-0.56 | $-1.59 | -183.9% | $613000 | +87.9% |
| Nov 7, 2024 | $-0.54 | $-6.96 | -1200.3% | $607000 | +52.8% |
| Dec 31, 2023 | — | $-0.14 | — | $2M | — |
| Sep 30, 2023 | — | $-0.09 | — | $621000 | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.